Pacira BioSciences, Inc. filed thirteen Post-Effective Amendments to its Form S-8 registration statements on November 17, 2026, deregistering all previously registered but unsold shares of common stock following the completion of its merger with Viatris Inc.

Key Highlights

  • Merger completed November 17, 2026: Peach Purchaser Sub Inc., a wholly owned subsidiary of Viatris, merged with and into Pacira BioSciences, with Pacira surviving as a wholly owned subsidiary of Viatris.
  • Thirteen registration statements terminated: The filings cover Registration Nos. 333-175101 through 333-297971, originally filed between June 2011 and August 2026.
  • All unsold shares removed from registration: According to the filing, after giving effect to the Post-Effective Amendments, no remaining shares are registered by the company under the covered registration statements.
  • Merger Agreement dated October 8, 2026: The transaction was governed by the Agreement and Plan of Merger among Pacira BioSciences, Viatris Inc., and Peach Purchaser Sub Inc.
  • Multiple equity plans covered: The deregistered shares were associated with plans including the Amended and Restated 2011 Stock Incentive Plan, the Amended and Restated 2014 Employee Stock Purchase Plan, and the Amended and Restated 2014 Inducement Plan, among others.
  • Signed by President Michael Rainerman: The Post-Effective Amendments were executed by Michael Rainerman in his capacity as President of Pacira BioSciences, Inc.

Pacira BioSciences Closes Out Employee Plan Registrations as Viatris Acquisition Takes Effect

Pacira BioSciences, Inc., a Delaware corporation headquartered at 2000 Sierra Point Parkway, Suite 900, Brisbane, California, filed Post-Effective Amendments to thirteen previously active Form S-8 registration statements on November 17, 2026. The company, listed on NASDAQ:PCRX and classified as a large accelerated filer, disclosed that the amendments were prompted by the completion of its acquisition by Viatris Inc., a Delaware corporation, through Viatris's wholly owned subsidiary Peach Purchaser Sub Inc. The merger was structured so that Peach Purchaser Sub Inc. merged with and into Pacira BioSciences, leaving Pacira BioSciences as a surviving wholly owned subsidiary of Viatris.

According to the filing, the thirteen affected registration statements were originally filed with the SEC over a span of more than fifteen years, beginning with Registration No. 333-175101 filed on June 23, 2011, and ending with Registration No. 333-297971 filed on August 4, 2026. Each statement related to one or more employee equity compensation plans, including the Pacira Pharmaceuticals, Inc. 2007 Stock Option/Stock Issuance Plan, the Amended and Restated 2011 Stock Incentive Plan, the Amended and Restated 2014 Employee Stock Purchase Plan, and the Amended and Restated 2014 Inducement Plan. Individual share registrations across these statements ranged from 175,000 shares to 4,000,000 shares in a single filing.

The filing states that as a result of the transactions contemplated by the Merger Agreement, Pacira terminated all offerings and sales under the registration statements and removed from registration all shares that remained unsold as of November 17, 2026. The company disclosed that after giving effect to the Post-Effective Amendments, there will be no remaining shares registered by the company pursuant to the covered registration statements. The amendments were signed by President Michael Rainerman in Brisbane, California.

What Was Disclosed

Pacira BioSciences filed thirteen Post-Effective Amendments to Form S-8 registration statements to deregister all unsold shares under multiple employee equity plans, following the November 17, 2026 completion of its acquisition by Viatris Inc. pursuant to a Merger Agreement dated October 8, 2026.